The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins
Abstract
Epidemiologic studies suggest a link between infection/inflammation and atherosclerosis. During the acute-phase response to infection and inflammation, cytokines induce tissue and plasma events that lead to changes in lipoprotein. Many of these changes are similar to those proposed to promote atherogenesis. The changes of lipoproteins during infection and inflammation are reviewed with a focus on those that are potentially proatherogenic. Hypertriglyceridemia, elevated triglyceride-rich lipoproteins, the appearance of small dense low-density lipoproteins, increased platelet-activating factor acetylhydrolase activity, and secretory phospholipase A(2), sphingolipid-enriched lipoproteins, and decreased high-density lipoprotein (HDL) cholesterol are changes that could promote atherogenesis. Moreover, alterations of proteins associated with HDL metabolism (e.g., paraoxonase, apolipoprotein A-I, lecithin:cholesterol acyltransferase, cholesterol ester transfer protein, hepatic lipase, phospholipid transfer protein, and serum amyloid A) could decrease the ability of HDL to protect against atherogenesis through antioxidation and reverse cholesterol transport mechanisms. These proatherogenic changes of lipoproteins may contribute to the link between infection/inflammation and atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 8×
“In agreement with these concepts, therapies that raise HDL and decrease triglyceride reduce the morbidity and mortality from CAD [27, 28].”
BackgroundInfluentialSCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Book ReviewAmbulatory Pediatric Care
Steinberg, J. B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901053200122 · Cited by 2,108
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547 · cited 1×
“On the other hand, plasma levels of HDL cholesterol are inversely correlated with the risk of atherosclerosis [26].”
BackgroundThe gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Molecular physiology of reverse cholesterol transport.
Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.-C., Deleuze, J.-F., Brewer, H. B., Duverger, N., Denèfle, P., et al. (1999) · Nature Genetics · doi:10.1038/11921 · Cited by 1,433
Dental disease and risk of coronary heart disease and mortality.
DeStefano, F., Anda, R. F., Kahn, H. S., Williamson, D. F., & Russell, C. M. (1993) · BMJ · doi:10.1136/bmj.306.6879.688 · Cited by 1,112
Stampfer, M. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110036029 · Cited by 1,079
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066 · cited 1×
“, VLDL and remnants) have recently reemerged as risk factors for atherosclerosis [24, 25].”
BackgroundRidker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,013
Kugiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R., & Henry, P. D. (1990) · Nature · doi:10.1038/344160a0 · Cited by 858
Grunfeld, C. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.5.1045 · Cited by 848
Self-citationGardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 8×
“Whether ceruloplasmin is prooxidant or antioxidant in vivo is uncertain, but plasma ceruloplasmin level is a risk factor for CAD [96].”
BackgroundInfluentialVan Lenten, B. J., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., La Du, B. N., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118345 · Cited by 840
Saikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 786
Lawn, R. M., Wade, D. P., Garvin, M. R., Wang, X., Schwartz, K., Porter, J. G., Seilhamer, J. J., Vaughan, A. M., & Oram, J. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8119 · Cited by 724
Relation of Helicobacter pylori infection and coronary heart disease.
Mendall, M. A., Goggin, P. M., Molineaux, N., Levy, J., Toosy, T., Strachan, D., Camm, A. J., & Northfield, T. C. (1994) · Heart · doi:10.1136/hrt.71.5.437 · Cited by 658
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
Tall, A. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114722 · Cited by 652
Quinn, M. T., Parthasarathy, S., & Steinberg, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2805 · Cited by 650
Libby, P., Egan, D., & Skarlatos, S. (1997) · Circulation · doi:10.1161/01.cir.96.11.4095 · Cited by 556
Chait, A., Brazg, R. L., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554
Cell cholesterol efflux: integration of old and new observations provides new insights
Rothblat, G. H., de la Llera-Moya, M., Atger, V., Kellner-Weibel, G., Williams, D. L., & Phillips, M. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32113-1 · Cited by 503
Plasma High-Density Lipoproteins
Tall, A. R., & Small, D. M. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811302992207 · Cited by 499
Clusterin: Physiologic and pathophysiologic considerations
Rosenberg, M. E., & Silkensen, J. (1995) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00027-m · Cited by 426
Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.
Feingold, K. R., & Grunfeld, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113046 · Cited by 403
Self-citationJiang, X.-C., Bruce, C., Mar, J., Lin, M., Ji, Y., Francone, O. L., & Tall, A. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5578 · Cited by 394
Gallin, J. I., Kaye, D., & O'Leary, W. M. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911132812001 · Cited by 370
Feingold, K., Staprans, I., Memon, R., Moser, A., Shigenaga, J., Doerrler, W., Dinarello, C., & Grunfeld, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41334-3 · Cited by 346
Self-citationSchissel, S. L., Tweedie-Hardman, J., Rapp, J. H., Graham, G., Williams, K. J., & Tabas, I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118934 · Cited by 341
Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
Oram, J. F., & Yokoyama, S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37453-8 · Cited by 341
Rapp, J. H., Lespine, A., Hamilton, R. L., Colyvas, N., Chaumeton, A. H., Tweedie-Hardman, J., Kotite, L., Kunitake, S. T., Havel, R. J., & Kane, J. P. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1767 · Cited by 340
Nigon, F., Lesnik, P., Rouis, M., & Chapman, M. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41629-3 · Cited by 326
Effects of endotoxin and cytokines on lipid metabolism
Hardardóttir, I., Grünfeld, C., & Feingold, K. R. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199405030-00008 · Cited by 304
Self-citationInterleukin-6 stimulates hepatic triglyceride secretion in rats
Nonogaki, K. (1995) · Endocrinology · doi:10.1210/en.136.5.2143 · Cited by 304
Cabana, V. G., Siegel, J. N., & Sabesin, S. M. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38390-5 · Cited by 300
Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.
Grunfeld, C., Kotler, D. P., Shigenaga, J. K., Doerrler, W., Tierney, A., Wang, J., Pierson, R. N., & Feingold, K. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90536-7 · Cited by 286
Self-citationCirculating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome
Grunfeld, C., Kotler, D. P., Shigenaga, J. K., Doerrler, W., Tierney, A., Wang, J., Pierson, R. N., & Feingold, K. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80154-e · Cited by 286
Self-citationChanges in serum lipoprotein pattern induced by acute infections
Sammalkorpi, K., Valtonen, V., Kerttula, Y., Nikkilä, E., & Taskinen, M.-R. (1988) · Metabolism · doi:10.1016/0026-0495(88)90120-5 · Cited by 275
Human Vascular Endothelial Cells Are a Rich and Regulatable Source of Secretory Sphingomyelinase
Marathe, S., Schissel, S. L., Yellin, M. J., Beatini, N., Mintzer, R., Williams, K. J., & Tabas, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4081 · Cited by 273
Platelet-activating Factor Acetylhydrolases
Stafforini, D. M., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17895 · Cited by 270
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
Ehrenwald, E., Chisolm, G. M., & Fox, P. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117127 · Cited by 261
Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response
Feingold, K. R., Memon, R. A., Moser, A. H., & Grunfeld, C. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00084-7 · Cited by 248
Self-citationIncreased de novo hepatic lipogenesis in human immunodeficiency virus infection
Hellerstein, M. K. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.3.559 · Cited by 245
Symptoms of chronic bronchitis and the risk of coronary disease
Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02374-4 · Cited by 244
Ivandic, B., Castellani, L. W., Wang, X.-P., Qiao, J.-H., Mehrabian, M., Navab, M., Fogelman, A. M., Grass, D. S., Swanson, M. E., de Beer, M. C., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1284 · Cited by 244
Steinbrecher, U. P., & Pritchard, P. H. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38359-0 · Cited by 215
Kisilevsky, R., & Subrahmanyan, L. (1992) · PubMed · Cited by 214
Multiple Cytokines Stimulate Hepatic Lipid Synthesis in Vivo*
FEINGOLD, K. R., SOUED, M., SERIO, M. K., MOSER, A. H., DINARELLO, C. A., & GRUNFELD, C. (1989) · Endocrinology · doi:10.1210/endo-125-1-267 · Cited by 210
Self-citationPsoriasis and occlusive vascular disease
MCDONALD, C. J., & CALABRESI, P. (1978) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1978.tb02012.x · Cited by 204
Monson, R. R., & Hall, A. P. (1976) · Journal of Chronic Diseases · doi:10.1016/0021-9681(76)90086-2 · Cited by 203
Memon, R. A. (1993) · Endocrinology · doi:10.1210/en.132.5.2246 · Cited by 193
Self-citationHoffman, J. S., & Benditt, E. P. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34047-x · Cited by 190
Johnson, W. J., Bamberger, M. J., Latta, R. A., et al. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38448-x · Cited by 184
Castellani, L. W., Navab, M., Van Lenten, B. J., Hedrick, C. C., Hama, S. Y., Goto, A. M., Fogelman, A. M., & Lusis, A. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119554 · Cited by 184
Cytomegalovirus and atherosclerosis.
Melnick, J. L., Adam, E., & DeBakey, M. E. (1993) · PubMed · Cited by 183
Tumor Necrosis Factor Stimulates Hepatic Lipid Synthesis and Secretion*
FEINGOLD, K. R., SERIO, M. K., ADI, S., MOSER, A. H., & GRUNFELD, C. (1989) · Endocrinology · doi:10.1210/endo-124-5-2336 · Cited by 183
Self-citationFeingold, K. R., Krauss, R. M., Pang, M., Doerrler, W., Jensen, P., & Grunfeld, C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501146 · Cited by 183
Self-citationFeingold, K. R., Hardardottir, I., Memon, R., Krul, E. J. T., Moser, A. H., Taylor, J. M., & Grunfeld, C. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35355-4 · Cited by 181
Self-citationAtherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman, M. J., Guérin, M., & Bruckert, É. (1998) · PubMed · Cited by 178
The Oxidation of Lipoproteins by Monocytes-Macrophages
Chisolm, G. M., Hazen, S. L., Fox, P. L., & Cathcart, M. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.25959 · Cited by 174
Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin
Samokyszyn, V. M., Miller, D. M., Reif, D. W., & Aust, S. D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31218-8 · Cited by 166
Memon, R. A., Holleran, W. M., Moser, A. H., Seki, T., Uchida, Y., Fuller, J., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.8.1257 · Cited by 165
Self-citationHurt-Camejo, E., Camejo, G., Rosengren, B., Lopez, F., Wiklund, O., & Bondjers, G. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42610-0 · Cited by 162
Xu, X. X., & Tabas, I. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54306-4 · Cited by 160
Leitinger, N., Watson, A. D., Hama, S. Y., Ivandic, B., Qiao, J.-H., Huber, J., Faull, K. F., Grass, D., Navab, M., Fogelman, A. M., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1291 · Cited by 154
Platelet‐activating factor: a mediator for clinicians
Imaizumi, T., Stafforini, D. M., Yamada, Y., et al. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb00894.x · Cited by 148
Serum ferritin and ceruloplasmin as coronary risk factors
Mänttäri, M., Manninen, V., HURRUNEN, J. K., Palosuo, T., Ehnholm, C., Heinonen, O. P., & Frick, M. H. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060440 · Cited by 144
Kunitake, S. T., Jarvis, M. R., Hamilton, R. L., & Kane, J. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6993 · Cited by 137
Feingold, K. R., Soued, M., Staprãns, I., Gavin, L. A., Donahue, M. E., Huang, B. J., Moser, A. H., Gulli, R., & Grünfeld, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113991 · Cited by 132
Self-citationHoffman, J. S., & Benditt, E. P. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110847 · Cited by 113
Ly, H., Francone, O. L., Fielding, C. J., Shigenaga, J. K., Moser, A. H., Grunfeld, C., & Feingold, K. R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41133-2 · Cited by 108
Self-citationJiang, X., & Bruce, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17133 · Cited by 101
Acidic pH enables caeruloplasmin to catalyse the modification of low‐density lipoprotein
Lamb, D. J., & Leake, D. S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80348-x · Cited by 95
Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues
Chatterjee, S. B., Dey, S., Shi, W. Y., Thomas, K., & Hutchins, G. M. (1997) · Glycobiology · doi:10.1093/glycob/7.1.57 · Cited by 92
Feingold, K. R., Soued, M., Adi, S., Staprãns, I., Neese, R. A., Shigenaga, J. K., Doerrler, W. T., Moser, A. H., Dinarello, C. A., & Grünfeld, C. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.495 · Cited by 91
Self-citationAuerbach, B. J., & Parks, J. S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81794-x · Cited by 90
Distribution and Synthesis of Apolipoprotein J in the Atherosclerotic Aorta
Ishikawa, Y., Akasaka, Y., Ishii, T., Komiyama, K., Masuda, S., Asuwa, N., Choi-Miura, N.-H., & Tomita, M. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.4.665 · Cited by 86
Harðardóttir, I., Moser, A. H., Fuller, J., Fielding, C. J., Feingold, K. K., & Grünfeld, C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118707 · Cited by 85
Self-citationGlycosphingolipid Accumulation in the Aortic Wall Is Another Feature of Human Atherosclerosis
Mukhin, D. N., Chao, F. F., & Kruth, H. S. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1607 · Cited by 83
High density associated enzymes: their role in vascular biology
Navab, M., Hama, S. Y., Hough, G. P., Hedrick, C. C., Sorenson, R. C., Du, B. N. L., KOBASHIGAWA, J. A., Fonarow, G. C., Berliner, J. A., Laks, H., et al. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00009 · Cited by 83
Ettinger, W., Miller, L. D., Albers, J., Smith, T. K., & Parks, J. S. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42750-6 · Cited by 79
Harðardóttir, I., Kunitake, S. T., Moser, A. H., Doerrler, W. T., Rapp, J. H., Grünfeld, C., & Feingold, K. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117449 · Cited by 72
Self-citationGianturco, S. H., Ramprasad, M. P., Song, R., Li, R., Brown, M. L., & Bradley, W. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.6.968 · Cited by 70
Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes.
Pruzanski, W., Vadas, P., & Browning, J. L. (1993) · PubMed · Cited by 69
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: Cellular aspects
Gianturco, S. H., & Bradley, W. A. (1999) · Clinical Cardiology · doi:10.1002/clc.4960221403 · Cited by 69
Krauss, R. M., Grünfeld, C., Doerrler, W. T., & FEINGOLD, K. R. (1990) · Endocrinology · doi:10.1210/endo-127-3-1016 · Cited by 66
Self-citationDifferential effects of interleukin-1 and tumor necrosis factor on ketogenesis
Memon, R. A., Feingold, K. R., Moser, A. H., Doerrler, W. T., Adi, S., Dinarello, C. A., & Grünfeld, C. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.2.e301 · Cited by 62
Self-citationEndotoxin and interleukin-1 decrease hepatic lipase mRNA levels
Feingold, K. R., Memon, R. A., Moser, A. H., Shigenaga, J. K., & Grünfeld, C. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00265-2 · Cited by 62
Self-citationGianturco, S. H., Eskin, S. G., Navarro, L. T., Lahart, C. J., Smith, L. C., & Gotto, A. M. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90061-2 · Cited by 59
Memon, R. A., Fuller, J., Moser, A. H., Feingold, K. R., & Grünfeld, C. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.1.r94 · Cited by 58
Self-citationFeingold, K. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.6.1423 · Cited by 57
Self-citationHarðardóttir, I., Sipe, J. D., Moser, A. H., Fielding, C. J., Feingold, K. R., & Grünfeld, C. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00143-9 · Cited by 55
Self-citationRegulation of Glycosphingolipid Metabolism in Liver during the Acute Phase Response
Memon, R. A., Holleran, W. M., Uchida, Y., Moser, A. H., Ichikawa, S., Hirabayashi, Y., Grünfeld, C., & Feingold, K. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19707 · Cited by 53
Self-citationRedgrave, T. G., Rakic, V., Mortimer, B., & Mamo, J. C. L. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90218-k · Cited by 44
Lipoprotein-Mediated Cellular Mechanisms for Atherogenesis in Hypertriglyceridemia
Gianturco, S. H., & Bradley, W. A. (1988) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002770 · Cited by 44
Howard, K. M., Miller, J. E., Miwa, M., & Olson, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27543 · Cited by 41
Khovidhunkit, W., Memon, R. A., Shigenaga, J. K., Pang, M., Schambelan, M., Mulligan, K. M., Feingold, K. R., & Grünfeld, C. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90240-8 · Cited by 37
Self-citationLipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo.
Nonogaki, K., Moser, A. H., Pan, X.-M., Staprãns, I., Grünfeld, C., & Feingold, K. R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41116-2 · Cited by 35
Self-citationHoffman, J. S., & Benditt, E. P. (1983) · Cited by 34
Clusterin (Apo J) regulates vascular smooth muscle cell differentiation in vitro
Moulson, C. L., & Millis, A. J. T. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199909)180:3<355::aid-jcp6>3.0.co;2-f · Cited by 22
Cited by
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Self-citationExplaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
Sattar, N., McCarey, D. W., Capell, H., & McInnes, I. B. (2003) · Circulation · doi:10.1161/01.cir.0000099844.31524.05 · Cited by 942
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Endoplasmic Reticulum Stress Activates Cleavage of CREBH to Induce a Systemic Inflammatory Response
Zhang, K., Shen, X., Wu, J., Sakaki, K., Saunders, T., Rutkowski, D. T., Back, S. H., & Kaufman, R. J. (2006) · Cell · doi:10.1016/j.cell.2005.11.040 · Cited by 716
Metadata
- Authors
- Khovidhunkit, Memon, R. A., Feingold, K. R., & Grunfeld, C.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-06
- Volume
- 181
- Issue
- s3
- Pages
- S462-S472
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2132235918
- Cited by
- 403
- References
- 116
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.